$KTRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kintara Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Kintara Therapeutics, Inc.. Get notifications about new insider transactions in Kintara Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | KTRA | Kintara Therapeuti ... | SEYMOUR TAMARA A | Director | Option Exercise | A | 1.37 | 75,000 | 102,750 | 75,000 | |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | C | 0.00 | 3,000 | 0 | 0 | |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | C | 0.00 | 750 | 0 | 6,818 | 6.1 K to 6.8 K (+12.36 %) |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 6 | 0 | 6,068 | 6.1 K to 6.1 K (+0.10 %) |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | C | 0.00 | 3,750 | 0 | 0 | |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | C | 0.00 | 938 | 0 | 8,486 | 7.5 K to 8.5 K (+12.43 %) |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 8 | 0 | 7,548 | 7.5 K to 7.5 K (+0.11 %) |
Mar 31 2021 | KTRA | Kintara Therapeuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 6,062 | 6 K to 6.1 K (+0.28 %) |
Mar 31 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,540 | 7.5 K to 7.5 K (+0.29 %) |
Jan 04 2021 | KTRA | Kintara Therapeuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 6,045 | 6 K to 6 K (+0.28 %) |
Jan 04 2021 | KTRA | Kintara Therapeuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.00 | 8 | 0 | 1,230 | 1.2 K to 1.2 K (+0.65 %) |
Jan 04 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,518 | 7.5 K to 7.5 K (+0.29 %) |
Sep 30 2020 | KTRA | Kintara Therapeuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.00 | 8 | 0 | 1,222 | 1.2 K to 1.2 K (+0.66 %) |
Sep 30 2020 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,496 | 7.5 K to 7.5 K (+0.29 %) |
Sep 30 2020 | KTRA | Kintara Therapeuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 6,028 | 6 K to 6 K (+0.28 %) |
Sep 24 2020 | KTRA | Kintara Therapeuti ... | Brown Dennis M | Chief Scientifc Off ... | Option Exercise | A | 1.36 | 60,000 | 81,300 | 60,000 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 1.70 | 606,557 | 1,031,147 | 606,557 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Liatos John | SVP, Business Devel ... | Option Exercise | A | 1.70 | 506,647 | 861,300 | 506,647 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | A | 1.70 | 87,437 | 148,643 | 87,437 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 1.70 | 2,715,004 | 4,615,507 | 2,715,004 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 1.70 | 120,000 | 204,000 | 120,000 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 1.70 | 120,000 | 204,000 | 120,000 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Murphy Keith | Director | Option Exercise | A | 1.70 | 120,000 | 204,000 | 120,000 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Johnson Laura L. | Director | Option Exercise | A | 1.70 | 120,000 | 204,000 | 120,000 | |
Aug 21 2020 | DMPI | Kintara Therapeuti ... | Liatos John | SVP, Business Devel ... | Buy | P | 0.00 | 196,750 | 0 | 196,750 | 0 to 196.8 K |
Aug 21 2020 | DMPI | Kintara Therapeuti ... | Murphy Keith | Director | Buy | P | 0.00 | 181,010 | 0 | 181,010 | 0 to 181 K |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 57,170 | 34,874 | 108,366 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,474 | 7.5 K to 7.5 K (+0.30 %) |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Sell | J | 0.00 | 8 | 0 | 332 | 340 to 332 (-2.35 %) |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 0.00 | 29 | 0 | 9,817 | 9.8 K to 9.8 K (+0.30 %) |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.00 | 8 | 0 | 1,214 | 1.2 K to 1.2 K (+0.66 %) |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Ferrara Napoleone | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 241,438 | 147,277 | 457,650 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | A | 0.74 | 250,000 | 183,750 | 250,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | A | 0.61 | 52,756 | 32,181 | 100,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 6,011 | 6 K to 6 K (+0.28 %) |
Mar 31 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,452 | 7.4 K to 7.5 K (+0.30 %) |
Mar 31 2020 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.00 | 8 | 0 | 1,206 | 1.2 K to 1.2 K (+0.67 %) |
Mar 31 2020 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Sell | J | 0.00 | 8 | 0 | 324 | 332 to 324 (-2.41 %) |
Mar 31 2020 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 0.00 | 29 | 0 | 9,788 | 9.8 K to 9.8 K (+0.30 %) |
Mar 31 2020 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 5,994 | 6 K to 6 K (+0.28 %) |
Jan 02 2020 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 5,977 | 6 K to 6 K (+0.29 %) |
Jan 02 2020 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Gift | G | 0.00 | 7,500 | 0 | 5,960 | 13.5 K to 6 K (-55.72 %) |
Jan 02 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,430 | 7.4 K to 7.4 K (+0.30 %) |
Jan 02 2020 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.00 | 8 | 0 | 1,198 | 1.2 K to 1.2 K (+0.67 %) |
Oct 01 2019 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.00 | 8 | 0 | 1,190 | 1.2 K to 1.2 K (+0.68 %) |
Oct 01 2019 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 0.00 | 8 | 0 | 308 | 300 to 308 (+2.67 %) |
Oct 01 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 0.00 | 29 | 0 | 9,730 | 9.7 K to 9.7 K (+0.30 %) |
Oct 01 2019 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 13,460 | 13.4 K to 13.5 K (+0.13 %) |
Sep 16 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 0.68 | 35,000 | 23,744 | 44,701 | 9.7 K to 44.7 K (+360.79 %) |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Ferrara Napoleone | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Ferrara Napoleone | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 39,567 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 39,567 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 39,567 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | A | 0.61 | 47,244 | 28,819 | 47,244 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | A | 0.61 | 52,756 | 32,181 | 52,756 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 216,212 | 131,889 | 216,212 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 241,438 | 147,277 | 241,438 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 39,567 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 51,196 | 31,230 | 51,196 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 57,170 | 34,874 | 57,170 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 39,567 | |
Jul 01 2019 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.00 | 8 | 0 | 1,182 | 1.2 K to 1.2 K (+0.68 %) |
Jul 01 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,386 | 7.4 K to 7.4 K (+0.30 %) |
Jul 01 2019 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 0.00 | 8 | 0 | 300 | 292 to 300 (+2.74 %) |
Jul 01 2019 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.00 | 17 | 0 | 13,443 | 13.4 K to 13.4 K (+0.13 %) |
Jul 01 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 0.00 | 29 | 0 | 9,701 | 9.7 K to 9.7 K (+0.30 %) |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | Ferrara Napoleone | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
Apr 01 2019 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.49 | 74 | 36 | 11,739 | 11.7 K to 11.7 K (+0.63 %) |
Apr 01 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.49 | 211 | 103 | 73,632 | 73.4 K to 73.6 K (+0.29 %) |
Apr 01 2019 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 0.49 | 71 | 35 | 2,912 | 2.8 K to 2.9 K (+2.50 %) |
Apr 01 2019 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.49 | 169 | 83 | 134,260 | 134.1 K to 134.3 K (+0.13 %) |
Apr 01 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 0.49 | 282 | 138 | 96,711 | 96.4 K to 96.7 K (+0.29 %) |
Jan 02 2019 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 0.34 | 74 | 25 | 11,665 | 11.6 K to 11.7 K (+0.64 %) |
Jan 02 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.34 | 211 | 72 | 73,421 | 73.2 K to 73.4 K (+0.29 %) |
Jan 02 2019 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 0.34 | 71 | 24 | 2,841 | 2.8 K to 2.8 K (+2.56 %) |
Jan 02 2019 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 0.34 | 282 | 96 | 96,429 | 96.1 K to 96.4 K (+0.29 %) |
Jan 02 2019 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 0.34 | 169 | 58 | 134,091 | 133.9 K to 134.1 K (+0.13 %) |
Jan 02 2019 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Gift | G | 0.00 | 85,000 | 0 | 133,922 | 218.9 K to 133.9 K (-38.83 %) |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | Ferrara Napoleone | Director | Option Exercise | A | 0.61 | 40,000 | 24,396 | 40,000 | |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 0.61 | 40,000 | 24,396 | 40,000 | |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 0.61 | 40,000 | 24,396 | 40,000 | |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 100,000 | 60,990 | 100,000 | |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 40,000 | 24,396 | 40,000 | |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 0.61 | 40,000 | 24,396 | 40,000 | |
Oct 01 2018 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,591 | 11.5 K to 11.6 K (+0.64 %) |
Oct 01 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 73,210 | 73 K to 73.2 K (+0.29 %) |
Oct 01 2018 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 2,770 | 2.7 K to 2.8 K (+2.63 %) |
Oct 01 2018 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 218,922 | 218.8 K to 218.9 K (+0.08 %) |
Oct 01 2018 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 96,147 | 95.9 K to 96.1 K (+0.29 %) |
Jul 03 2018 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,517 | 11.4 K to 11.5 K (+0.65 %) |
Jul 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 72,999 | 72.8 K to 73 K (+0.29 %) |
Jul 03 2018 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 2,699 | 2.6 K to 2.7 K (+2.70 %) |
Jul 03 2018 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 95,865 | 95.6 K to 95.9 K (+0.30 %) |
Jun 26 2018 | DMPI | DelMar Pharmaceuti ... | Ferrara Napoleone | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Jun 26 2018 | DMPI | DelMar Pharmaceuti ... | Ferrara Napoleone | Director | Option Exercise | A | 0.70 | 54,514 | 38,160 | 54,514 | |
May 22 2018 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.98 | 836,465 | 821,827 | 836,465 | |
Apr 17 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Apr 17 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 1.06 | 36,000 | 38,160 | 36,000 | |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,443 | 11.4 K to 11.4 K (+0.65 %) |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 72,788 | 72.6 K to 72.8 K (+0.29 %) |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 528 | 1,690 | 8,222 | 7.7 K to 8.2 K (+6.86 %) |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 2,628 | 2.6 K to 2.6 K (+2.78 %) |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 218,584 | 218.4 K to 218.6 K (+0.08 %) |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 95,583 | 95.3 K to 95.6 K (+0.30 %) |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Buy | J | 3.20 | 176 | 563 | 64,049 | 63.9 K to 64 K (+0.28 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 218,415 | 218.2 K to 218.4 K (+0.08 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Gift | G | 0.00 | 129,600 | 0 | 218,246 | 347.8 K to 218.2 K (-37.26 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | A | 4.95 | 93,600 | 463,320 | 93,600 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | D | 4.95 | 93,600 | 463,320 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | A | 4.20 | 87,500 | 367,500 | 87,500 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | D | 4.20 | 87,500 | 367,500 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | A | 2.00 | 37,500 | 75,000 | 37,500 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | D | 2.00 | 37,500 | 75,000 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Buy | J | 3.20 | 176 | 563 | 63,873 | 63.7 K to 63.9 K (+0.28 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 2,557 | 2.5 K to 2.6 K (+2.86 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | C | 0.00 | 25,000 | 0 | 72,577 | 47.6 K to 72.6 K (+52.55 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 47,577 | 47.4 K to 47.6 K (+0.45 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,369 | 11.3 K to 11.4 K (+0.66 %) |
Nov 16 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Interim CEO | Buy | P | 0.84 | 5,900 | 4,956 | 5,900 | 0 to 5.9 K |
Nov 16 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Interim CEO | Buy | P | 0.82 | 55,000 | 45,100 | 55,000 | 0 to 55 K |
Nov 07 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Interim CEO | Option Exercise | A | 0.87 | 120,000 | 104,400 | 120,000 | |
Oct 10 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 0.88 | 2,450 | 2,156 | 63,697 | 61.2 K to 63.7 K (+4.00 %) |
Oct 10 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 0.87 | 7,550 | 6,569 | 61,247 | 53.7 K to 61.2 K (+14.06 %) |
Oct 05 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | P | 0.85 | 17,500 | 14,910 | 47,366 | 29.9 K to 47.4 K (+58.60 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 53,697 | 53.5 K to 53.7 K (+0.33 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 75,019 | 74.7 K to 75 K (+0.38 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 885,346 | 885.2 K to 885.3 K (+0.02 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 2,486 | 2.4 K to 2.5 K (+2.94 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 528 | 1,690 | 7,166 | 6.6 K to 7.2 K (+7.95 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | J | 3.20 | 211 | 675 | 29,866 | 29.7 K to 29.9 K (+0.71 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,295 | 11.2 K to 11.3 K (+0.66 %) |
Aug 02 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
Aug 02 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | C | 0.00 | 25,000 | 0 | 74,737 | 49.7 K to 74.7 K (+50.26 %) |
Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 |